Kevin Ridley is an accomplished tax executive with extensive experience in developing and implementing tax strategies across various industries. Currently serving as the VP and Interim Head of Tax at Angi, Kevin oversees the organization's tax strategy, compliance, and planning. Previous roles include Head of Tax and VP & Chief Tax Officer at Coherus Oncology, where Kevin achieved over $5 million in annual income tax savings, and Head of Tax at Corcept Therapeutics, focusing on global tax strategy optimization. Kevin's expertise also spans positions at ZELTIQ Aesthetics, Levi Strauss & Co., McKesson, and Deloitte, contributing to significant tax savings and regulatory compliance throughout a diverse career. Kevin holds a Master of Science in Taxation from Golden Gate University and a Bachelor of Science in Business Administration/Accounting from California State University - East Bay.
This person is not in any teams
This person is not in any offices